Filing Details

Accession Number:
0001437749-19-024861
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-12-26 10:48:32
Reporting Period:
2019-12-22
Accepted Time:
2019-12-26 10:48:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1158895 Lemaitre Vascular Inc LMAT Surgical & Medical Instruments & Apparatus (3841) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1365733 Jr P Joseph Pellegrino C/O Lemaitre Vascular, Inc.
63 Second Avenue
Burlington MA 01803
Chief Financial Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-12-22 6 $0.00 30,032 No 4 M Direct
Common Stock Disposition 2019-12-22 181 $35.48 29,851 No 4 F Direct
Common Stock Disposition 2019-12-24 300 $36.07 29,551 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Dividend Equivalent Rights Disposition 2019-12-22 6 $0.00 6 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
16 No 4 M Direct
Footnotes
  1. Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
  2. These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 22, 2017. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
  3. This transaction was effected pursuant to a Rule 10b5-1 trading plan established by the Reporting Person.
  4. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $36.04 to $36.11. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
  5. These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 22, 2017. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.